According to Paratek Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.10. In 2022 the company made an earnings per share (EPS) of -$1.18 an increase over its 2021 EPS that were of -$1.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.10 | -6.78% |
2022 | -$1.18 | -3.28% |
2021 | -$1.22 | -44.29% |
2020 | -$2.19 | -44.27% |
2019 | -$3.93 | 10.08% |
2018 | -$3.57 | 6.57% |
2017 | -$3.35 | -40.5% |
2016 | -$5.63 | 33.1% |
2015 | -$4.23 | -55.46% |
2014 | -$9.50 | -45.8% |
2013 | -$17.52 | 92.11% |
2012 | -$9.12 | 162.07% |
2011 | -$3.48 | -57.97% |
2010 | -$8.28 | -64.06% |
2009 | -$23.04 | -49.99% |
2008 | -$46.07 | -44.5% |
2007 | -$83.01 | -76.9% |
2006 | -$359.39 | -64.83% |
2005 | -$1,022 | 2.84% |
2004 | -$993.60 |